During the past decade, Teikyo University conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Teikyo University" #1 collaborator was "Arthritis Research UK" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator, "Taiho Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "The National Institute of Biomedical Innovation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Teikyo University" are "Coronary Disease" (3 trials), "Coronary Artery Disease" (2 trials), "Coronary Artery Stenosis" (2 trials), "Coronary Restenosis" (2 trials) and "Myocardial Ischemia" (2 trials). Many other conditions were trialed in "Teikyo University" in a lesser frequency.

Most popular intervention types in "Teikyo University" are "Device" (2 trials), "Drug" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABSORB BVS" (1 trials), "Azathioprine" (1 trials), "Oxaliplatin" (1 trials), "Radiation" (1 trials) and "Rituximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Teikyo University" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Teikyo University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Teikyo University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Teikyo University, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".